These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R. J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014 [Abstract] [Full Text] [Related]
7. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Coordinators. Am Heart J; 2007 Jan 02; 153(1):82.e1-11. PubMed ID: 17174643 [Abstract] [Full Text] [Related]
8. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L. Am Heart J; 2003 Feb 02; 145(2):292-9. PubMed ID: 12595847 [Abstract] [Full Text] [Related]
9. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S, MUCHA Investigators. Am Heart J; 2004 Feb 02; 147(2):324-30. PubMed ID: 14760332 [Abstract] [Full Text] [Related]
11. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice. Massie BM, Nelson JJ, Lukas MA, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, Lottes SR, Franciosa JA, COHERE Participant Physicians. Am J Cardiol; 2007 May 01; 99(9):1263-8. PubMed ID: 17478155 [Abstract] [Full Text] [Related]
13. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. de Groote P, Delour P, Mouquet F, Lamblin N, Dagorn J, Hennebert O, Le Tourneau T, Foucher-Hossein C, Verkindère C, Bauters C. Am Heart J; 2007 Sep 01; 154(3):589-95. PubMed ID: 17719311 [Abstract] [Full Text] [Related]
15. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis. Shore S, Aggarwal V, Zolty R. J Card Fail; 2012 Dec 01; 18(12):919-24. PubMed ID: 23207080 [Abstract] [Full Text] [Related]
16. Discharge use of carvedilol is associated with higher survival in Japanese elderly patients with heart failure regardless of left ventricular ejection fraction. Yanagihara K, Kinugasa Y, Sugihara S, Hirai M, Yamada K, Ishida K, Kato M, Yamamoto K. J Cardiovasc Pharmacol; 2013 Nov 01; 62(5):485-90. PubMed ID: 24072178 [Abstract] [Full Text] [Related]
19. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Tatli E, Kurum T. Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561 [Abstract] [Full Text] [Related]